Skip to main content

HighCape Capital Acquisition Corp. II (HCCR)

HighCape Capital Acquisition II will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Market Cap256.00M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out25.60M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Price Targetn/a
Est. Earnings Daten/a

About HCCR

HighCape Capital Acquisition II is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to focus on industries that complement our management team’s background in life sciences and life sciences related industries, and to capitalize on the ability of our management team to identify and acquire a business within those industries. We intend to focus our investment effort ...

IndustryBlank Checks / SPAC
IPO DatePending
CEOKevin Rakin
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolHCCR
Full Company Profile


Life sciences SPAC HighCape Capital Acquisition II files for a $200 million IPO

HighCape Capital Acquisition II, the second blank check company formed by HighCape Capital targeting life sciences, filed on Wednesday with the SEC to raise up to $200 million in an initial public offer...

6 months ago - NASDAQ

HighCape Capital Acquisition II IPO Registration Document (S-1)

HighCape Capital Acquisition Corp. II has filed to go public with an IPO on the NASDAQ.

6 months ago - SEC